69729-836-20 : NDC 2026 Code

69729-836-20 : Dextromethorphan Hbr, Guaifenesin ( Tabcin )

Additionally :

You can get information about “69729-836-20” NDC code in 69729-836-20 in HTML format

HTML | 69729-836-20 in TXT (Plain Text) format

TXT | 69729-836-20 in PDF (Portable Document Format)

PDF | 69729-836-20 in XML format

XML formats.

NDC Code : 69729-836-20 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "69729-836-20",
    "PackageDescription": "1 BLISTER PACK in 1 CARTON (69729-836-20)  / 20 CAPSULE, LIQUID FILLED in 1 BLISTER PACK",
    "NDC11Code": "69729-0836-20",
    "ProductNDC": "69729-836",
    "ProductTypeName": "HUMAN OTC DRUG",
    "ProprietaryName": "Tabcin",
    "ProprietaryNameSuffix": "Extra Strength",
    "NonProprietaryName": "Dextromethorphan Hbr, Guaifenesin",
    "DosageFormName": "CAPSULE, LIQUID FILLED",
    "RouteName": "ORAL",
    "StartMarketingDate": "20260907",
    "EndMarketingDate": null,
    "MarketingCategoryName": "OTC MONOGRAPH DRUG",
    "ApplicationNumber": "M012",
    "LabelerName": "OPMX LLC",
    "SubstanceName": "DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN",
    "StrengthNumber": "20; 400",
    "StrengthUnit": "mg/1; mg/1",
    "Pharm_Classes": "Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2026-10-12",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20271231",
    "StartMarketingDatePackage": "20260907",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}